Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2011 1
2012 3
2013 7
2014 1
2015 3
2016 7
2017 8
2018 4
2019 6
2020 8
2021 9
2022 8
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.
Mulcahy MF, Mahvash A, Pracht M, Montazeri AH, Bandula S, Martin RCG 2nd, Herrmann K, Brown E, Zuckerman D, Wilson G, Kim TY, Weaver A, Ross P, Harris WP, Graham J, Mills J, Yubero Esteban A, Johnson MS, Sofocleous CT, Padia SA, Lewandowski RJ, Garin E, Sinclair P, Salem R; EPOCH Investigators. Mulcahy MF, et al. Among authors: mahvash a. J Clin Oncol. 2021 Dec 10;39(35):3897-3907. doi: 10.1200/JCO.21.01839. Epub 2021 Sep 20. J Clin Oncol. 2021. PMID: 34541864 Free PMC article. Clinical Trial.
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.
Morris VK, Salem ME, Nimeiri H, Iqbal S, Singh P, Ciombor K, Polite B, Deming D, Chan E, Wade JL, Xiao L, Bekaii-Saab T, Vence L, Blando J, Mahvash A, Foo WC, Ohaji C, Pasia M, Bland G, Ohinata A, Rogers J, Mehdizadeh A, Banks K, Lanman R, Wolff RA, Streicher H, Allison J, Sharma P, Eng C. Morris VK, et al. Among authors: mahvash a. Lancet Oncol. 2017 Apr;18(4):446-453. doi: 10.1016/S1470-2045(17)30104-3. Epub 2017 Feb 18. Lancet Oncol. 2017. PMID: 28223062 Free PMC article. Clinical Trial.
Minimally invasive image-guided therapies for hepatocellular carcinoma.
Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC. Abdelsalam ME, et al. Among authors: mahvash a. J Hepatocell Carcinoma. 2016 Oct 11;3:55-61. doi: 10.2147/JHC.S92732. eCollection 2016. J Hepatocell Carcinoma. 2016. PMID: 27785450 Free PMC article. Review.
Preoperative drainage for perihilar cholangiocarcinoma.
Odisio BC, Krampitz GW, Murthy R, Mahvash A, Javle M, Vauthey JN. Odisio BC, et al. Among authors: mahvash a. Lancet Gastroenterol Hepatol. 2019 Jan;4(1):10-11. doi: 10.1016/S2468-1253(18)30345-5. Epub 2018 Dec 6. Lancet Gastroenterol Hepatol. 2019. PMID: 30527574 No abstract available.
Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma.
Lam M, Garin E, Palard-Novello X, Mahvash A, Kappadath C, Haste P, Tann M, Herrmann K, Barbato F, Geller B, Schaefer N, Denys A, Dreher M, Fowers KD, Gates V, Salem R. Lam M, et al. Among authors: mahvash a. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):245-257. doi: 10.1007/s00259-023-06416-9. Epub 2023 Sep 12. Eur J Nucl Med Mol Imaging. 2023. PMID: 37698645 Free PMC article.
Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features.
Tran Cao HS, Witt RG, Elsayes KM, Baiomy AA, Xiao L, Palmquist S, Lee SS, Mohamed YI, Mahvash A, Tzeng CD, Chun YS, Koay EJ, Rashid A, Hassan MM, Yao JC, Vauthey JN, Kaseb AO. Tran Cao HS, et al. Among authors: mahvash a. Oncologist. 2023 Dec 30:oyad329. doi: 10.1093/oncolo/oyad329. Online ahead of print. Oncologist. 2023. PMID: 38159256 Free article.
A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study.
Mahvash A, Chartier S, Turco M, Habib P, Griffith S, Brown S, Kappadath SC. Mahvash A, et al. BMC Gastroenterol. 2022 Mar 28;22(1):151. doi: 10.1186/s12876-022-02204-1. BMC Gastroenterol. 2022. PMID: 35346070 Free PMC article.
69 results